← Open Payments lookup

AMBER KEENAN: Open Payments

NPI 1972022465 · NAPA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$791 in 32 payments from 12 companies in 2025. Trend: 2023 $949 · 2024 $756 · 2025 $791

Food & beverage: $791
CompanyPaymentsAmount
GENZYME CORPORATION12$212
CSL Behring1$114
Genentech USA, Inc.3$71
GlaxoSmithKline, LLC.3$68
Regeneron Healthcare Solutions, Inc.2$58
Novartis Pharmaceuticals Corporation2$55
Ionis Pharmaceuticals, Inc.2$54
BioCryst US Sales Co., LLC2$46
Kowa Pharmaceuticals America, Inc.2$42
Takeda Pharmaceuticals U.S.A., Inc.1$27

Products named: DUPIXENT, Andembry, Xolair, NUCALA, DAWNZERA, ORLADEYO, ZORYVE, CUVITRU.

Industry payments across CA — which companies pay providers there.